|4Feb 23, 12:22 PM ET

FERRARI LOUIS 4

4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 23, 2012

Insider Transaction Report

Form 4
Period: 2012-02-22
FERRARI LOUIS
SVP, North American Commerical
Transactions
  • Sale

    Common Stock, $.01 par value per share

    2012-02-22$2.06/sh4,100$8,446350,503 total
Footnotes (1)
  • [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 21, 2011.

Documents

1 file
  • 4
    rrd335579.xmlPrimary